It's helping patients improve their overall health and create lasting changes that support them for years to come." Men concerned about their weight, diabetes, sleep apnea, or other obesity-related health conditions should talk with their healthcare provider about whether GLP-1 medications may be appropriate for them
We manage every step of prior authorizations for weight loss drugs, verify your benefits, and liaise with insurers to answer crucial questions, such as "does insurance cover weight loss medication?" This ensures a seamless journey, regardless of your insurer, be it Medicaid, Aetna, Blue Cross Blue Shield, UnitedHealthcare, or Cigna
The obesity pharmacotherapy space continues to evolve with additional therapies in the pipeline including maritide (a GLP-1RA/GIP antagonist), cagrisema (a GLP-1RA/amylin RA), and retatrutide (a GLP-1RA /GIP/glucagon RA) which have shown promise in clinical trials [76]
Have a health profile that may qualify for GLP-1 therapy
Yes, patients with metabolic dysfunction-associated steatotic liver disease (MASLD) can generally use GLP-1 receptor agonists safely
enough energy, it would seem, to drive biological reactions